Australian health authorities have approved a new weight loss drug to help fight obesity. The weight loss drug Contrave has been listed on the Australian Register of Therapeutic Goods and is intended to be used with a diet control and increased exercise, according to a media report.
Australian Researcher Michael Cowley, Head of the Monash Biomedicine Discovery Institute's Department of Physiology, developed the medication while working overseas after mapping key areas of the brain involved in the regulation of food intake.
Cowley said he hopes the extra medication on the market, which has been approved for use in the US since 2014, will help people realise there are effective medical treatments available.
That will also help break down inappropriate social stigma, he said.